Home › Funds › SurgoCap Partners LP › MDLN

SurgoCap Partners LP position in MDLN

MEDLINE INC · Health Care

SurgoCap Partners LP reported holding 7,487,507 shares of MDLN (MEDLINE INC) in its Q2 2026 13F filing — a position valued at US$295.3M, representing 9.55% of its reported portfolio and ranking #5 among its reported holdings. SurgoCap Partners LP has disclosed MDLN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)7.49M sh
Reported value held$295.31M
Portfolio Weight9.55%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SurgoCap Partners LP's MDLN position evolved

SurgoCap Partners LP first disclosed a stake in MDLN in Q1 2026 at 6,075,165 shares (US$270.3M). The position peaked in Q2 2026 at 7,487,507 shares, worth US$295.3M. Across 2 filings, SurgoCap Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 7,487,507 shares valued at US$295.3M — an increase of 1,412,342 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 6.08M $270.34M New
Q2 2026 7.49M $295.31M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDLN and 13F data

MDLN (MEDLINE INC) is a Health Care company. 116 other funds we track also report a position in MDLN — the largest reported positions include Carlyle Group Inc. (US$7.38B), Blackstone Inc. (US$4.01B), H&F Corporate Investors X, Ltd. (US$2.80B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDLN

All MDLN fund holders →

FAQ

How long has SurgoCap Partners LP held MDLN?

SurgoCap Partners LP has disclosed MDLN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is SurgoCap Partners LP's current position in MDLN?

As of Q2 2026, SurgoCap Partners LP holds 7.49M shares of MDLN (MEDLINE INC), valued at $295.31M, representing 9.55% of its reported portfolio and ranking #5.

Has SurgoCap Partners LP been buying or selling MDLN?

In the latest 13F filing (Q2 2026), SurgoCap Partners LP increased its position in MDLN. The position peaked in Q2 2026 at 7.49M shares.

Which other funds hold MDLN?

Other major institutional holders of MDLN include Carlyle Group Inc., Blackstone Inc., H&F Corporate Investors X, Ltd., among 116 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.